📰 Reduced Intensity News

Reduced Intensity News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Reduced Intensity. Real-time updates on events, politics, business and more.

New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

December 12, 2023

/PRNewswire/ -- Johnson & Johnson announced today an analysis from the Phase 1/2 MonumenTAL-1 study of TALVEY™ (talquetamab-tgvs) in patients with relapsed or...

United States San Francisco Christie Corbett Satu Glawe Christoph Heuck American Society Of Hematology

Source: prnewswire.com

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatmen

December 10, 2023

– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen in younger patients across disease control, non-relapse mortality and overall survival –– Orca-T in older patients given a reduced intensity conditioning regim...

United States Joshua Murray Samer Srour Ivan Dimov Kelsey Grossman Department Of Stem Cell Transplantation

Source: pharmiweb.com

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

December 9, 2023

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

New York United States North Vancouver British Columbia Gabriel Friedman Joshua Murray

Source: financialpost.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Reduced Intensity News Today

New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY&#x2122; in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatmen

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

Explore More Categories

New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma